Drugs & medicalClass II

Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only,…

CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Read the official notice →
Date
2025-01-15
Country
United States
Brand
Rising Pharma Holding
Product
Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only,…
Classification
Class II
Units
Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Rising Pharma Holding recalls

  1. 2026-03-11
  2. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc.,…

    Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

    FDA · DrugRising Pharma Holding, Inc.Nationwide within the U.SOfficial notice →
  3. 2025-10-22
  4. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings,…

    Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and…

    FDA · DrugRising Pharma Holding, Inc.Distributed Nationwide in the USAOfficial notice →
  5. 2025-03-26
  6. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USA.Official notice →
  7. 2024-12-11
  8. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99)…

    CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit

    FDA · DrugRising Pharma Holding, Inc.Nationwide.Official notice →
  9. 2024-07-17
  10. US
    Drugs & medicalClass III

    Rising Pharma Holding, Inc. recalls Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising…

    Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USAOfficial notice →
  11. 2024-06-12
  12. US
    Drugs & medicalClass III

    Rising Pharma Holding, Inc. recalls Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816,…

    Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as…

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USAOfficial notice →
All 9 Rising Pharma Holding recalls →

Other drugs & medical recalls in the United States

  1. 2025-01-15
  2. US
    Drugs & medicalClass I

    Maquet Cardiovascular, LLC recalls VasoView HemoPro 2 Endoscopic Vessel Harvesting System. Model Numbers: VH-4000. Indicated for use in minimally invasive surgery…

    Potential for two issues: 1. Bent or detached heater wire; 2. Silicone peeling or detaching from the Jaws of the Harvesting Tool

    FDA · DeviceMaquet Cardiovascular, LLCNationwide distribution. International distribution to Australia, Austria,…Official notice →
  3. US
    Drugs & medicalClass II

    Granules Pharmaceuticals Inc. recalls Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000-count bottles, Rx Only, Manufactured by: Granules India…

    Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.

    FDA · DrugGranules Pharmaceuticals Inc.Distributor in OH.Official notice →
  4. US
    Drugs & medicalClass II

    Jubilant Draximage Inc., dba Jubilant Radiopharma recalls Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection, 10 mL Multi-Dose Reaction Vial, 5 vial…

    Failed Stability Specifications

    FDA · DrugJubilant Draximage Inc., dba Jubilant RadiopharmaUS Nationwide.Official notice →
  5. US
    Drugs & medicalClass II

    Granules Pharmaceuticals Inc. recalls Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC…

    Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.

    FDA · DrugGranules Pharmaceuticals Inc.Nationwide within the United StatesOfficial notice →
  6. US
    Drugs & medicalClass II

    Eugia US LLC recalls Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ…

    Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

    FDA · DrugEugia US LLCDistributed Nationwide in the USA.Official notice →
  7. US
See all drugs & medical recalls →